Public Pathology Australia releases updates and comments on critical issues facing the pathology sector.

Contact Public Pathology Australia’s CEO Jenny Sikorski on or 0466 576 221 for comment.

Some of Public Pathology Australia’s releases are contained below.

SA Pathology to Remain in Public Ownership

Public Pathology Australia welcomes SA Premier and Health Minister’s decision to keep SA Pathology in public ownership – demonstrating the value and importance of public pathology services, especially during the #COVID19 pandemic.

Click here for media release.

Pathology testing should be a level playing field – for patients and providers

Published 29 May 2018

Australians value access to affordable, high quality health care and, although it’s not always the first health service that springs to mind, access to pathology testing is an important aspect of this.

In the post below, CEO of Public Pathology Australia, Jenny Sikorski, says there are currently some threats to the viability of  smaller pathology services in under-served areas. She explains how this has come about, and outlines what needs to be done ensure that everyone in Australia has equitable access to diagnostic testing.

Click for full article.

MYEFO MBS Pathology Cuts May Cause Patients to Avoid Necessary Testing

Published 16 December 2015

The Federal Government’s announcement in the Mid-Year Economic and Fiscal Outlook (MYEFO) to remove the bulk billing incentive for pathology providers from 1 July next year may impact on the health of patients.  The government has made a decision to cut MBS fees outside the agreed MBS Review process and without considering the impact on patients and the pathology sector.

Public pathology services are under considerable financial pressure.  They do not receive the same amount of Medicare funding for the same tests as the private sector.  Cutting the bulk billing incentive may cause private pathology providers to start charging co-payments or to charge higher co-payments for pathology services and this can deter patients from having vital pathology tests done.  Public pathology providers will not cease bulk billing patients for Medicare services as they have a responsibility to provide comprehensive access for all Australians and communities, including those who are ‘hard to reach’ either due to geography, disability of socio-economic factors.

Click for full media release.

Contact Public Pathology Australia for further information on the posted release or any of the following:

  • what pathology is
  • how pathology services are funded
  • recently announced pathology changes
  • what public pathology services do and who they are